Interim reports

SynAct Pharma: Interim Report January-June 2021 August 27, 2021 (Q2 2021 Report included)

“Positive data of AP1189 in Covid-19 patients bodes well for the future. The hard work at the start of the year continued in the second quarter as SynAct Pharma made additional progress on its pipeline. T... Read more

SynAct Pharma: Interim report January-March 2021

“The first three months have indeed given a strong and convincing start of the new year to SynAct Pharma, when we continued to make significant progress on our projects and put the company in a unique p... Read more